Please login to the form below

Not currently logged in
Email:
Password:

emerging markets

This page shows the latest emerging markets news and features for those working in and with pharma, biotech and healthcare.

Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention

Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention

US-based, Ridgeback is focused on emerging infectious diseases and markets monoclonal antibody Ebanga (ansuvimab-zykl) for the treatment of Ebola.

Latest news

More from news
Approximately 13 fully matching, plus 357 partially matching documents found.

Latest Intelligence

  • Back to the future Back to the future

    Business models that aimed to compete on customer intimacy were polarising between small audiences – so called health concierges – and mass markets, which is Fitbit’s emerging model. ... By and large, I feel pretty vindicated. The six great shifts

  • Pharma funding and M&A in 2020 Pharma funding and M&A in 2020

    As we see with Takeda – and as we’ve seen with other industries, notably tech – companies from fast- growing emerging markets continue to rise.

  • BRIC markets BRIC markets

    The idea was to illustrate the growing importance of emerging economies relative to developed markets and to encourage the G7 to factor them into policymaking. ... He added: “The hype about BRIC markets is cooler than it used to be.

  • The mission matters The mission matters

    Developed and emerging markets differ greatly but there are also great differences between developed markets, such as Europe and the US. ... And within markets, therapy areas differ hugely, ranging from rare diseases and oncology to primary care and

  • Leading AstraZeneca’s return to growth in Europe Leading AstraZeneca’s return to growth in Europe

    Now the business has two particularly strong growth drivers: emerging markets, most especially China, and oncology, where a triumvirate of drugs – Tagrisso, Imfinzi and Lynparza – have hit a major growth phase. ... So does AstraZeneca believe there

More from intelligence
Approximately 14 fully matching, plus 62 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 35 partially matching documents found.

Latest from PMHub

  • Breaking the silence: It’s time to talk about the menopause

    We are experts in Female Health and have conducted over 80 projects covering a wide range of global markets. ... In addition, we have specialised Emerging Markets and Behavioural Science teams, who we work in collaboration with to help pharmaceutical

  • What does the future hold for Light-chain Amyloidosis?

    We found spontaneous awareness of new developments and approvals to be very limited in all markets. ... In addition, we have specialised Emerging Markets and Behavioural Science teams, who we work in collaboration with to help pharmaceutical clients

  • How femtech is changing the future of women's health How femtech is changing the future of women's health

    Women’s health and the next billion users. For femtech, the next big challenge and the next big opportunity is the emerging markets.

  • Webcast

    China: How pharma can maximize success in this rapidly changing emerging market. ... Watch this webcast in which Research Partnership's emerging market experts explore the recent 2020 healthcare reforms, digital transformations as a result of COVID-19,

  • Article: Spotlight on Mexico

    Healthcare under AMLO – One year on. In this article, Rachel Howard and local expert Dr Xavier Tello, discuss the latest changes in the healthcare system and consider what they mean for pharmaceutical manufacturers wishing to enter the Mexican

More from PMHub
Approximately 68 fully matching, plus 42 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....